Recurrent Cervical Cancer

Also known as: Cervical cancer recurrent / Carcinoma uterine cervix recurrent / Cervical carcinoma recurrent / Ca cervix recurrent / Carcinoma uterine cerix recurrent / Cervix uteri cancer recurrent / Cervix carcinoma recurrent / Carcinoma cervix recurrent

DrugDrug NameDrug Description
DB00112BevacizumabA recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.
DB00361VinorelbineVinorelbine (Navelbine®) is an anti-mitotic chemotherapy drug that is given as a treatment for some types of cancer, including breast cancer and non-small cell lung cancer. [Wikipedia]